🇺🇸 FDA

Intelligence · Clinical Pipeline

R&D Pipeline Programs

ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.

Programs indexed
20,548
Companies
1,769
Drugs tracked
4,797

Quick answer

NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.

4,413 results for “ACE” Clear

  1. Livmarli Oral Product

    Mirum Pharmaceuticals International B.V.

    Alagille Syndrome

    approved small molecule active

    1 trial

  2. Lotilaner ophthalmic solution, 0.25%

    Tarsus Pharmaceuticals

    Demodex Blepharitis

    approved small molecule completed

    1 trial

  3. METHOTREXATE , MYCOPHENOLIC ACID , AZATHIOPRINE , Tavneos 10 mg hard capsules, CYCLOPHOSPHAMIDE , -, RITUXIMAB, Placebo for AMG 569

    Amgen

    Antineutrophil cytoplasmic antibody-associated vasculitis (AAV)

    approved small molecule active

    1 trial

  4. Mailed nicotine replacement therapy

    BRIGHT MINDS BIOSCIENCES INC.

    Smoking Cessation

    approved small molecule completed

    1 trial

  5. Managed Ventricular Pacing programmed ON/OFF

    Rhythm Pharmaceuticals Netherlands B.V.

    Cardiovascular Diseases

    approved other completed

    1 trial

  6. MedPulser Electroporation with bleomycin

    INOVIO PHARMACEUTICALS, INC.

    Cancer

    approved other completed

    1 trial

  7. Medpulser electroporation with Bleomycin

    INOVIO PHARMACEUTICALS, INC.

    Head and Neck Cancer

    approved other terminated

    2 trials

  8. Medtronic AT500

    Rhythm Pharmaceuticals Netherlands B.V.

    Atrial Fibrillation

    approved other completed

    1 trial

  9. Medtronic Endeavor Resolute

    Rhythm Pharmaceuticals Netherlands B.V.

    Coronary Artery Disease

    approved other completed

    1 trial

  10. Mekinist, DRB436, DRB436, TMT212, TMT212, Mekinist 0.5 mg film-coated tablets, DRB436, Mekinist 2 mg film-coated tablets

    Novartis Pharmaceuticals

    Children and Adolescents with Cancers Harboring V600 mutation.

    approved small molecule active

    1 trial

  11. Monthly Review Arm

    Rhythm Pharmaceuticals Netherlands B.V.

    Heart Failure

    approved other completed

    1 trial

  12. Morphine

    COLLEGIUM PHARMACEUTICAL, INC

    ST-segment Elevation Myocardial Infarction

    approved small molecule completed

    1 trial

  13. N-acetycysteine (600mg twice daily)

    Kwong Wah Hospital

    COPD

    approved small molecule completed

    1 trial

  14. Naglazyme

    BioMarin Pharmaceutical Australia Pty Ltd

    Mucopolysaccharidosis VI

    approved small molecule completed

    1 trial

  15. Naltrexone HCl/Bupropion HCl Placebo

    Takeda

    Weight Regain Post Bariatric Surgery

    approved small molecule terminated

    1 trial

  16. Neffy

    Ars Pharmaceuticals Irl Limited

    Allergic Reactions

    approved small molecule active

    1 trial

  17. Neovascular Age-related Macular Degeneration

    Novartis Pharmaceuticals

    Neovacular Age-related Macular Degeneration

    approved other completed

    1 trial

  18. Normal Saline

    Nanjing Zenshine Pharmaceuticals

    Breast Feeding

    approved small molecule completed

    1 trial

  19. ONTAK (denileukin difitox, DAB389IL-2)

    LIGAND PHARMACEUTICALS INC

    Lymphoma, T-Cell, Cutaneous

    approved small molecule completed

    1 trial

  20. Ofatumumab

    Novartis Pharmaceuticals

    Relapsing Multiple Sclerosis

    approved mab completed

    1 trial

  21. Offer of voucher for cost-free Nicotine Replacement Therapy

    United Therapeutics Europe Ltd

    Tobacco Smoking

    approved small molecule completed

    1 trial

  22. Ofirmev

    CUMBERLAND PHARMACEUTICALS INC

    Pain

    approved small molecule completed

    1 trial

  23. Olutasidenib

    RIGEL PHARMACEUTICALS INC

    AML (Acute Myeloid Leukemia)

    approved small molecule active

    1 trial

  24. Oxymetazoline HCL 1.0% Cream

    Aclaris Therapeutics

    Rosacea

    approved small molecule completed

    1 trial

Frequently asked questions

What is the NovaPharmaNews pipeline directory?

It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.

Where does pipeline data come from?

Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.

How do I find pipeline programs by company or phase?

Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.

Data attribution and licensing: Data sources